Ventana Biotech Stock Price To Sales
| VNTA Stock | USD 0.0004 0.00 0.00% |
Ventana Biotech fundamentals help investors to digest information that contributes to Ventana Biotech's financial success or failures. It also enables traders to predict the movement of Ventana Pink Sheet. The fundamental analysis module provides a way to measure Ventana Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ventana Biotech pink sheet.
Ventana |
Ventana Biotech Company Price To Sales Analysis
Ventana Biotech's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Ventana Biotech has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Financial Services sector and about the same as Shell Companies (which currently averages 0.0) industry. The price to sales for all United States stocks is 100.0% higher than that of the company.
Ventana Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ventana Biotech's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ventana Biotech could also be used in its relative valuation, which is a method of valuing Ventana Biotech by comparing valuation metrics of similar companies.Ventana Biotech is currently under evaluation in price to sales category among its peers.
Ventana Fundamentals
| Current Valuation | 165.2 K | |||
| Shares Outstanding | 55.07 M | |||
| Price To Earning | (1.00) X | |||
| Gross Profit | (260) | |||
| EBITDA | (36.71 K) | |||
| Net Income | (47.08 K) | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (54.01 K) | |||
| Earnings Per Share | (0) X | |||
| Beta | -2.08 | |||
| Market Capitalization | 192.73 K |
About Ventana Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ventana Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ventana Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ventana Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ventana Pink Sheet
Ventana Biotech financial ratios help investors to determine whether Ventana Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ventana with respect to the benefits of owning Ventana Biotech security.